Literature DB >> 25568861

Innate immune signaling and gut-liver interactions in non-alcoholic fatty liver disease.

Veerle Bieghs1, Christian Trautwein1.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome and covers a disease spectrum ranging from steatosis to inflammation, fibrosis, cirrhosis and hepatocellular carcinoma (HCC). The innate immune response in the liver plays an important role during NAFLD progression. In addition, changes in the intestinal microbial balance and bacterial translocation can further affect disease progression. Immune cells in the liver recognize cell damage or pathogen invasion with intracellular or surface-expressed pattern recognition receptors (PRRs), subsequently initiating signaling cascades that trigger the release of factors promoting the inflammatory response during NAFLD progression. Therefore, mechanisms by which cells of the immune system are activated and recruited into the liver and how these cells cause injury and stress are important for understanding the inflammatory response during NAFLD.

Entities:  

Keywords:  Liver inflammation; gut-liver axis; inflammasome; innate immunity; toll-like receptors (TLRs)

Year:  2014        PMID: 25568861      PMCID: PMC4273113          DOI: 10.3978/j.issn.2304-3881.2014.12.04

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN: 2304-3881            Impact factor:   7.293


  65 in total

Review 1.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

2.  Modulation of non-alcoholic steatohepatitis by pattern recognition receptors in mice: the role of toll-like receptors 2 and 4.

Authors:  Gyongyi Szabo; Arumugam Velayudham; Laszlo Romics; Pranoti Mandrekar
Journal:  Alcohol Clin Exp Res       Date:  2005-11       Impact factor: 3.455

3.  Kupffer cell activation by lipopolysaccharide in rats: role for lipopolysaccharide binding protein and toll-like receptor 4.

Authors:  G L Su; R D Klein; A Aminlari; H Y Zhang; L Steinstraesser; W H Alarcon; D G Remick; S C Wang
Journal:  Hepatology       Date:  2000-04       Impact factor: 17.425

Review 4.  Gut microbial adaptation to dietary consumption of fructose, artificial sweeteners and sugar alcohols: implications for host-microbe interactions contributing to obesity.

Authors:  A N Payne; C Chassard; C Lacroix
Journal:  Obes Rev       Date:  2012-06-11       Impact factor: 9.213

5.  Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium.

Authors:  Muriel Derrien; Elaine E Vaughan; Caroline M Plugge; Willem M de Vos
Journal:  Int J Syst Evol Microbiol       Date:  2004-09       Impact factor: 2.747

6.  High prevalence of small intestinal bacterial overgrowth in patients with morbid obesity: a contributor to severe hepatic steatosis.

Authors:  Jean-Marc Sabaté; Pauline Jouët; Florence Harnois; Charlotte Mechler; Simon Msika; Maggy Grossin; Benoît Coffin
Journal:  Obes Surg       Date:  2008-02-20       Impact factor: 4.129

7.  High-fat diet determines the composition of the murine gut microbiome independently of obesity.

Authors:  Marie A Hildebrandt; Christian Hoffmann; Scott A Sherrill-Mix; Sue A Keilbaugh; Micah Hamady; Ying-Yu Chen; Rob Knight; Rexford S Ahima; Frederic Bushman; Gary D Wu
Journal:  Gastroenterology       Date:  2009-08-23       Impact factor: 22.682

Review 8.  Does fructose consumption contribute to non-alcoholic fatty liver disease?

Authors:  Luc Tappy; Kim-Anne Lê
Journal:  Clin Res Hepatol Gastroenterol       Date:  2012-07-12       Impact factor: 2.947

9.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.

Authors:  Jorge Henao-Mejia; Eran Elinav; Chengcheng Jin; Liming Hao; Wajahat Z Mehal; Till Strowig; Christoph A Thaiss; Andrew L Kau; Stephanie C Eisenbarth; Michael J Jurczak; Joao-Paulo Camporez; Gerald I Shulman; Jeffrey I Gordon; Hal M Hoffman; Richard A Flavell
Journal:  Nature       Date:  2012-02-01       Impact factor: 49.962

Review 10.  Immune and inflammatory pathways in NASH.

Authors:  Michal Ganz; Gyongyi Szabo
Journal:  Hepatol Int       Date:  2013-08-30       Impact factor: 6.047

View more
  20 in total

Review 1.  Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis.

Authors:  A L L Rocha; L C Faria; T C M Guimarães; G V Moreira; A L Cândido; C A Couto; F M Reis
Journal:  J Endocrinol Invest       Date:  2017-06-13       Impact factor: 4.256

Review 2.  The dormant blood microbiome in chronic, inflammatory diseases.

Authors:  Marnie Potgieter; Janette Bester; Douglas B Kell; Etheresia Pretorius
Journal:  FEMS Microbiol Rev       Date:  2015-05-03       Impact factor: 16.408

Review 3.  Innate immune regulatory networks in hepatic lipid metabolism.

Authors:  Lan Bai; Hongliang Li
Journal:  J Mol Med (Berl)       Date:  2019-03-19       Impact factor: 4.599

4.  The Effect of Intraoperative N-Acetylcysteine on Hepatocellular Injury During Laparoscopic Bariatric Surgery. A Randomised Controlled Trial.

Authors:  Ajay P Belgaumkar; Kirstin A Carswell; Robin D Hughes; Alberto Quaglia; Anil Dhawan; Ragai R Mitry; Ameet G Patel
Journal:  Obes Surg       Date:  2016-06       Impact factor: 4.129

5.  Emerging roles of myeloid derived suppressor cells in hepatic inflammation and fibrosis.

Authors:  Linda Hammerich; Frank Tacke
Journal:  World J Gastrointest Pathophysiol       Date:  2015-08-15

Review 6.  Non-alcoholic fatty liver diseases: from role of gut microbiota to microbial-based therapies.

Authors:  Hamed Ebrahimzadeh Leylabadlo; Reza Ghotaslou; Hossein Samadi Kafil; Mohammad Mehdi Feizabadi; Seyed Yaghoub Moaddab; Safar Farajnia; Elham Sheykhsaran; Sarvin Sanaie; Dariush Shanehbandi; Hossein Bannazadeh Baghi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-11       Impact factor: 3.267

Review 7.  Innate Immunity and Inflammation in NAFLD/NASH.

Authors:  Marco Arrese; Daniel Cabrera; Alexis M Kalergis; Ariel E Feldstein
Journal:  Dig Dis Sci       Date:  2016-02-03       Impact factor: 3.199

Review 8.  The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD).

Authors:  Zahra Safari; Philippe Gérard
Journal:  Cell Mol Life Sci       Date:  2019-01-25       Impact factor: 9.207

Review 9.  Nonalcoholic Lipid Accumulation and Hepatocyte Malignant Transformation.

Authors:  Juanjuan Gu; Min Yao; Dengbing Yao; Li Wang; Xuli Yang; Dengfu Yao
Journal:  J Clin Transl Hepatol       Date:  2016-06-15

10.  Protective Effects of Celastrol on Diabetic Liver Injury via TLR4/MyD88/NF-κB Signaling Pathway in Type 2 Diabetic Rats.

Authors:  Li-Ping Han; Chun-Jun Li; Bei Sun; Yun Xie; Yue Guan; Ze-Jun Ma; Li-Ming Chen
Journal:  J Diabetes Res       Date:  2016-01-19       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.